Featured
Last news
Medical Care Technologies Inc. (OTCID:MDCE) Advances Infinite Auctions Supply Talks With Fanatics / Topps After Knicks Championship
Subsidiary Deepens Game-Worn Memorabilia Path Into a Multi-Billion-Dollar Collectibles Platform, With Historic New York Knicks Material Now in Negotiation
NanoViricides Presenting at NIBA's 153rd Investment Conference in Fort Lauderdale, FL October 7, 2026
SHELTON, CT / ACCESS Newswire / October 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) ("the Company") is pleased to announce that it will be presenting tomorrow October 7, 2026 at NIBA's 153rd Investment Conference in Fort Lauderdale, Florida.
Belhaven Biopharma Initiates Pivotal Study of BBP01, a Nasal Powder Formulation of Epinephrine to Treat Anaphylaxis
Randomized crossover trial will compare the pharmacokinetics and pharmacodynamics of intranasal epinephrine powder against intramuscular auto-injector and manual injection in healthy participants
What Is the Typical Cost of a Mommy Makeover in Florida?
The Typical Cost of a Mommy Makeover in Florida Ranges From $9,999 to $14,000
TSR's Matt Hagan Holds 2026 NHRA Points Lead Post Semi-Final Run at St. Louis in American Rebel Light Beer Funny Car with Three Races Left in Championship Chase
American Rebel Light Beer featured as the Primary Sponsor on Matt Hagan's American Rebel Light Beer Dodge Hellcat Funny Car celebrates Hagan earning five qualifying bonus points, two round wins and a St. Louis semifinal finish as the 2026 regular-season champion, Matt Hagan pursues his fifth world title. Win Hagan Win!
INEO to Present at LD Micro 20th Annual Main Event on October 21, 2026
CEO Kyle Hall to present in Los Angeles at 1:00 p.m. Pacific Time
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
SYMON-II Clinical Validation Dataset Represents a Key Milestone as Bluejay Advances the Symphony™ IL-6 Test Toward Regulatory Submission
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 06
LONDON, UK / ACCESS Newswire / October 6, 2026 / The Company announces that on 05 October 2026 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.
Trump says US moved bombers from UK base after 'threats'
President Donald Trump said Monday that the United States had withdrawn all B-1 bombers from a British airbase because of unspecified threats that he believed were linked to Iran.
ICC unseals arrest warrants for Taliban education ministers
The International Criminal Court on Monday unsealed arrest warrants for two Afghan education ministers accused of committing crimes against humanity through the Taliban government's restrictions on women and girls.
Turkey blocks X account of British reporter
Turkish authorities have blocked the X account of a journalist for British broadcaster Sky News, she said Monday, in the latest wave of social media censorship that a rights group denounced as a "tsunami".
Disgraced former US House speaker dies at 84
Dennis Hastert, the longest-serving Republican speaker of the US House of Representatives whose career ended in disgrace after he admitted sexually abusing teenage boys he had coached, has died aged 84, officials said Monday.
Ukraine blames Russia for deadly sinking of Turkish ship in Black Sea
Russian drones carried out a deadly attack on a grain ship in the Black Sea on Monday, Ukrainian President Volodymyr Zelensky said, after Romania reported a ship had caught fire and sunk near its coast with two crew killed.
US withdraws all bomber aircraft from UK airbase
The United States confirmed that it had withdrawn all B-1 bombers from the British airbase of RAF Fairford, reportedly due to "new threats," with Britain's government insisting Monday the site is safe.
Alleged Indian leader of neo-Nazi child abuse ring goes on trial in Paris
An Indian man went on trial in Paris on Monday, accused of running a neo-Nazi child exploitation ring in which young girls were allegedly coerced into performing sexual acts online and engaging in self-harm.
Myanmar says 10,000 migrants returned from Malaysia this year
Myanmar has repatriated nearly 10,000 migrants from Malaysia this year, state media said on Monday, a day after a flotilla returning almost 1,500 of its citizens docked in the country.
Three years on, Israeli rescuer cannot escape October 7
Israeli rescuer Natan Kenig says it does not take much of a trigger for him to relive the October 7, 2023 attack: his eyes open or closed, at home or out with friends, he still sees the rockets, torched cars and lifeless bodies.
Acurx Pharmaceuticals Takes Its Antibiotics Story Global Through a 12-Month Series with New to The Street
Monthly long-form interviews will air on Bloomberg Television across four regions and on New to The Street TV's YouTube channel, which has more than 5.3 million subscribers (over 6.5 million together with its NewsOut channel). The program also includes TV commercials and accredited investor events.
Medical Care Technologies Inc. (OTCID:MDCE) Rolls Out Snapshot Recipes Optimizations and a Fresh Promotional Push
Faster App Experience and New Campaigns Aimed at Turning Grocery Photos and Meal Images Into Recipe Ideas
BODYWELLE Announces Exclusive Use of ZEO ScientifiX Biologics for Pain, Joints, and Wound Care Treatments
The Miami Beach practice now uses quantified stem cell and extracellular vesicle products, along with an autologous option derived from the patient's own platelets.
NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
SHELTON, CT / ACCESS Newswire / October 5, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, herewith provides additional details on its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus (BDBV) and other Ebola viruses in the Democratic Republic of Congo ("DRC").
Utah Medical Products, Inc. Extends Tender Offer
SALT LAKE CITY, UT / ACCESS Newswire / October 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The Offer was initially scheduled to expire at 5:00 p.m. New York City time, on Wednesday October 7. In order to allow all stockholders sufficient time to make their decisions, UTMD is extending the expiration date to 5:00 p.m. New York City time, on Tuesday October 27. The time extension provides the added benefit of allowing stockholders to consider UTMD's latest financial results for calendar 3Q 2026 which are scheduled to be announced on Thursday October 22.
New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
Jensen, who as CEO led Nasdaq-listed biotech Allarity Therapeutics' refocusing around a single lead asset, cites Valion's rare combination of government funding, FDA designations, human safety data and wholly owned U.S. manufacturing
Chervon Appoints Neil Harrison to the Position of VP Sales, Marketing and MD for Chervon Canada
NAPERVILLE, IL / ACCESS Newswire / October 5, 2026 / Neil Harrison joins Chervon as Vice President Sales, Marketing and Managing Director for Chervon Canada; effective Monday, October 5, 2026, reporting to CEO Joe Galli.
Chervon Names Claudio Chiappetta Vice President of Retail Sales for Chervon Canada
NAPERVILLE, IL / ACCESS Newswire / October 5, 2026 / Claudio Chiappetta joins Chervon as Vice President of Retail Sales for Chervon Canada; effective Monday, October 5, 2026, reporting to VP, MD Neil Harrison.
Chervon Names Peter J. Carlson Director of Sales for Strategic Accounts
NAPERVILLE, IL / ACCESS Newswire / October 5, 2026 / Peter J. Carlson joins Chervon as Director of Sales for Strategic Accounts effective Monday, October 5, 2026, reporting to SVP of Industrial and Commercial Sales, Jeff Campbell.
Hypha Labs Targets Disruptive Mushroom Active Ingredient Production
Eight-Day Cycles and Potential 80% Cost Savings
Chervon Names Daniel L. Abbott Director of Sales - Western U.S.A.
NAPERVILLE, IL / ACCESS Newswire / October 5, 2026 / Daniel L. Abbott joins Chervon as Director of Sales - Western U.S.A.; effective Monday, October 5, 2026, reporting to SVP Matt DeFeo.
Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary
FutureBrand Hispanic America onboards Vicapsys and delivers a unified visual identity for Vicapsys Life Sciences and its Stateline subsidiaryTwo linked brands under one visual system: Vicapsys as the umbrella brand and Stateline as the operating brand, now being applied across corporate materials, investor communications, Stateline's commercial documents and packaging, and the Company's public disclosuresThe identity rollout is the first of the Company's post-merger housekeeping steps; its OTCID application, Rule 15c2-11 quotation process and PCAOB audit are underway alongside it
Nepra Foods Introduces Nepra Wellness, Unifying Its Expanding Food, Beverage and Wellness Platform
New market-facing identity brings together the Company's operating capabilities under "One Platform. Many Brands."
Genflow Biosciences PLC Announces Presentation of Interim Results
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Presentation of Interim Results from SLAB Canine Study at the Animal Longevity Summit
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 05
Purchase of own shares